ChromoGenics announced last night that thay received an order of SEK5m for ConverLight dynamic glass...
Redeye is favorable to the news that Lifeclean has appointed a new permanent CEO.
Redeye takes a positive stance regarding Kontigo Care’s proposed directed share issue of approximate...
Q3e sales SEK 221m, up 11%, adj. EBITA margin 7.2% (8.
Reser betydande kapital Egetis meddelade under tisdagskvällen att de reser 462 mkr, varav 172 mkr ge...
Alltainer meddelade den 3 oktober att bolaget har beslutat att genomföra en nyemission av aktier med...
On 12 October, Fiskars lowered its adjusted EBIT guidance for 2023 from EUR 120-130m to EUR 100-120m...
We lower adjusted EBIT by 1-2% for 2023E-25E ahead of Elanders' Q3 2023 report.
11% CAGR in net profit for 2022-25e... ...and 10-11% dividend yield p.
13% CAGR in adjusted EPS for 2022-'25e Q3e: 7% NII growth q-o-q and another strong quarter on tradin...
Fiskars lowers its guidance for 2023 and published preliminary information of Q3.
Rapportkommentar, Q4 Diamyd presenterade under onsdagen sin bokslutskommuniké för det brutna räkensk...
Bivoca has signed a direct bill contract providing access to DiviTum TKa to appropriate patients tre...
Redeye endorses Lifecare's disclosure of its laboratory in Mainz being considered ready for ISO 1348...
Scanfil cut FY ‘23 guidance down a bit, but the news wasn’t big and EBIT should stay above EUR 60m a...
Yesterday evening, Fragbite Group announced that it acquired 100% of the shares in the gaming studio...
Redeye comments on Nanexa’s preliminary key financial information for Q3.
Redeye provides an additional comment on the news that Egetis Therapeutics has secured in total SEK4...
Stabil tillväxt med imponerande marginalexpansion Förvärv har historiskt stått för två tredjedelar a...
Redeye is encouraged by the recent announcement from Egetis Therapeutics that it has secured a total...
